Skip to main content

Table 2 Performance of seven algorithms under the 100 trials of 50% HOCV

From: A high performance profile-biomarker diagnosis for mass spectral profiles

Dataset

Ave. classification rate ± std (%)

Ave. sensitivity ± std (%)

Ave. specificity ± std (%)

Colorectal

   

mica-svm

99.05±01.82

98.84±03.41

99.28±01.82

svm

95.71±02.01

95.28±03.67

96.19±02.88

pca-svm

95.37±01.98

93.60±04.18

96.83±02.93

ica-svm

95.57±02.02

93.69±04.11

97.11±02.81

nmf-svm

92.46±02.97

89.91±06.92

94.65±04.04

lda

87.39±04.60

84.97±07.56

89.36±06.11

pca-lda

94.21±02.75

93.87±03.64

94.51±04.03

HCC

   

mica-svm

99.07±01.03

98.82±01.73

99.31±01.62

svm

93.08±02.33

93.42±03.55

92.95±04.12

pca-svm

89.65±02.86

89.09±04.46

90.33±04.59

ica-svm

90.15±02.63

89.76±04.27

90.70±04.35

nmf-svm

89.81±03.17

87.68±07.28

92.22±05.14

lda

89.48±03.67

91.55±04.42

87.75±06.88

pca-lda

91.20±02.81

90.08±05.18

92.38±03.62

Ovarian-qaqc

   

mica-svm

99.09±01.09

98.94±02.15

99.25±01.11

svm

97.64±01.36

97.42±02.04

97.86±02.18

pca-svm

98.63±00.88

99.28±01.20

98.12±01.58

ica-svm

98.52±00.83

99.06±01.30

98.10±01.50

nmf-svm

92.47±03.23

94.23±03.72

91.15±04.89

lda

81.42±04.48

87.86±05.17

76.26±06.91

pca-lda

98.42±01.04

99.30±01.13

97.73±01.94

Prostate

   

mica-svm

99.36±00.99

99.09±01.43

99.64±01.66

svm

95.91±02.09

95.75±03.05

96.18±03.99

pca-svm

97.94±01.65

98.48±01.70

97.43±03.24

ica-svm

98.23±01.61

98.36±01.84

98.14±02.84

nmf-svm

91.21±04.67

94.44±04.70

87.46±06.69

lda

89.92±04.77

94.43±04.65

85.02±10.46

pca-lda

97.50±02.20

97.90±02.50

97.10±03.25

Cirrhotic

   

mica-svm

99.52±00.85

99.44±01.65

99.62±00.95

svm

95.10± 03.17

92.97± 05.91

96.71± 03.10

pca-svm

91.52± 03.76

88.00± 08.39

94.15± 03.86

ica-svm

92.07± 03.41

88.47± 07.92

94.72± 03.48

nmf-svm

88.03±03.10

80.43±07.84

93.42±03.62

lda

86.66±06.11

86.57±10.30

86.93±08.19

pca-lda

92.39±03.62

89.04±07.45

94.83±03.48